Koyfin Home > Directory > Health Care > Arena Pharmaceutical > Long-term Debt / Equity

Arena Pharmaceutical Long-term Debt / Equity Chart (ARNA)

Arena Pharmaceutical annual/quarterly Long-term Debt / Equity from 2000 to 2018.
  • Arena Pharmaceutical Long-term Debt / Equity for the quarter ending December 12, 2018 was $9m a -18.74% decrease of -2m year over year
  • Arena Pharmaceutical Long-term Debt / Equity for the last 12 months ending December 12, 2018 was $9m a -18.74% decrease of -2m year over year
  • Arena Pharmaceutical Annual Long-term Debt / Equity for 2018 was $9m a -212.93% decrease of -19m from 2017
  • Arena Pharmaceutical Annual Long-term Debt / Equity for 2017 was $28m a -448.32% decrease of -125m from 2016
  • Arena Pharmaceutical Annual Long-term Debt / Equity for 2016 was $153m a 20.26% increase of 31m from 2015
Other Ratios Metrics:
  • Arena Pharmaceutical Total Debt / Capital for the quarter ending September 09, 2018 was $10m a -127.22% decrease of -13m year over year
  • Arena Pharmaceutical Other Liabilities for the quarter ending September 09, 2018 was $1m a -69.22% decrease of -1m year over year
  • Arena Pharmaceutical Total Debt / Equity for the quarter ending September 09, 2018 was $11m a -165.14% decrease of -19m year over year
View Chart On Koyfin

Quarterly ARNA Long-term Debt / Equity Data

12/2018$9m
09/2018$11m
06/2018$11m
03/2018$11m
12/2017$28m
09/2017$27m
06/2017$72m
03/2017$228m
12/2016$153m
09/2016$1,537m

Annual ARNA Long-term Debt / Equity Data

2018$9m
2017$28m
2016$153m
2015$122m
2014$144m
2013$77m
2012$74m
2011$844m
2010$129m
2009$185m